Warren Averett Asset Management, LLC Humacyte, Inc. Transaction History
Warren Averett Asset Management, LLC
- $5.34 Billion
- Q3 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 63,570 shares of HUMA stock, worth $323,571. This represents 0.01% of its overall portfolio holdings.
Number of Shares
63,570
Previous 10,832
486.87%
Holding current value
$323,571
Previous $51,000
576.47%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
150Shares Held
35.1MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$36.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$25.7 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$24.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$10.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$6.45 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $524M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...